Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993186priorityCriticalpatent/ECSP993186A/en
Publication of ECSP993186ApublicationCriticalpatent/ECSP993186A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se obtienen formulaciones de liberaciòn controlada sòlidas, de administarciòn por via oral al someter el ingrediente activo y un compuesto gardo a proceso de granulaciòn por fusiòn y mezclado posterior del granulado obteniendo con un polìmero hidrofìlico y excipientes convencionales.Solid controlled release formulations are obtained, administered orally by subjecting the active ingredient and a compound to a granulation process by fusion and subsequent mixing of the granulate, obtaining with a hydrophilic polymer and conventional excipients.
PROCESS FOR THE PREPARATION OF A COMPRESSED BETAHISTINE CONTROLLED LIBERATION BY GRANULATION IN THE FOUNDED STATE AND COMPRESSED CONTROLLED RELEASE OF BETAHISTIN OBTAINED BY MEANS OF THIS PROCESS
Compounds derived from 1- [3- (phenylamino) -5- (pyridin-4-yl) -1h-1,2,4-triazol-1-yl] -alkyl-2-ol; pharmaceutical composition; process for preparing said composition; and use for the treatment or prevention of a disease of the central nervous system.